Physician profile
Jonathan Yelda
NPI 1386489359
$1,457.91
in general payments reported to CMS, 2019-2025
10 companies · $1,099 in 2025
The $1,099 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $359 · 2025: $1,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,457.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $367.62 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Tela Bio, INC. | $162.48 | 2024 | Ovitex 2s |
| Baxter Healthcare | $156.23 | 2025 | Floseal, Perclot |
| Aroa Biosurgery Incorporated | $130.09 | 2025 | |
| Csl Behring | $125.00 | 2025 | Kcentra |
| Bard Peripheral Vascular, INC. | $118.64 | 2025 | Venovo |
| Haemonetics Corporation | $104.95 | 2024 | Teg6s Hemostasis System |
| Boston Scientific Corporation | $100.85 | 2025 | Ekosonic |
| Ethicon US, LLC | $100.79 | 2025 | Vistaseal, Echelon Circular, Dermabond Prineo |
| Smith+Nephew, INC. | $91.26 | 2024 | Pico |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Yelda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.